In healthcare leadership, some operational risks are subtle. Others hide in plain sight.
In 2026, the single most persistent and expensive threat to U.S. clinical outcomes isn’t lack of clinical innovation—it is medication non-adherence.
When patients with chronic conditions skip doses, delay refills, split pills to save money, or stop taking prescriptions altogether, the systemic costs compound rapidly.
The result is:
Over $300 billion in avoidable U.S. healthcare spending and 125,000 preventable deaths every single year.
For Chief Medical Officers, ACO directors, and Medicare Advantage executives operating under value-based care (VBC) contracts, non-adherence isn’t just an unfortunate patient habit.
It is a direct threat to financial solvency.
2026 CMS Star Ratings: How Non-Adherence Erodes VBC Margins
Despite state-of-the-art Electronic Health Records (EHRs) and e-prescribing tools, up to 50% of patients with chronic disease do not take their medications as prescribed.
Under 2026 value-based care frameworks, non-adherence destabilizes performance across three core operational areas:
- CMS Star Ratings Vulnerability: The Centers for Medicare & Medicaid Services (CMS) closely tracks Part D medication adherence across three core chronic categories: Diabetes, Hypertension (RAS Antagonists), and Cholesterol (Statins).
Drops in your population’s Proportion of Days Covered (PDC) score drag down overall contract ratings, directly threatening Medicare Advantage Quality Bonus Payments.
- Escalated Total Cost of Care: Unmanaged non-adherence fuels chronic disease decompensation.
When a diabetic or hypertensive patient stops taking prescribed therapy, uncontrolled blood sugar and blood pressure lead directly to emergency room visits and expensive 30-day hospital readmissions.
- HEDIS and Quality Penalties: Value-based contracts penalize practices that fail to close clinical quality gaps.
Poor adherence degrades blood pressure control and glycemic target metrics, causing practices to miss shared savings benchmarks.
What Non-Adherence Looks Like: 6 Risky Behaviors in Practice
To solve non-adherence, clinical leaders must recognize what it actually looks like in daily practice.
It is rarely a simple case of “forgetting a pill.” Non-adherence typically manifests in six distinct ways:
- Primary Non-Fill: The prescription is sent electronically to the retail pharmacy, but the patient never picks it up due to unexpected co-pays or initial confusion.
- Pill Splitting: Patients stretch their supply by taking half-doses or skipping alternate days to reduce out-of-pocket pharmacy expenses.
- Unintentional Skipping: Cognitive overload, complex daily dosing schedules, or lack of family caregiver support cause erratic dosing.
- Premature Stopping: Patients stop taking their medication as soon as their blood pressure or blood sugar readings stabilize, assuming they are cured.
- OTC Interference: Patients introduce over-the-counter supplements or pain medications (such as NSAIDs) that counter or blunt their prescribed therapy’s effectiveness.
- Regimen Hoarding: Taking outdated prescriptions or sharing medications with family members when symptoms recur.
Why EHR Alerts and Reminder Apps Fail
Over the past decade, health systems have poured millions into digital reminder apps, automated SMS alerts, and EHR portal notifications. Still, national adherence rates remain stubbornly flat.
Passive technology fails because it cannot address human clinical complexity:
- Push Notifications Don’t Fix Side Effects: A text alert reminding a patient to take a statin does nothing if the patient stopped taking it due to unaddressed muscle pain.
- EHR Alerts Don’t Lower Copays: An automated portal message cannot resolve the financial barrier of a high co-insurance bill at the pharmacy counter.
- Digital Tools Miss Polypharmacy Risks: A reminder app tracks scheduled times, but it cannot analyze whether three different prescribing specialists inadvertently introduced high-risk drug interactions.
“Increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments.”
— World Health Organization (WHO)
The Pharmacist-Led Solution: Medication Risk Management in Practice
Medication Therapy Management (MTM) turns adherence from a passive tracking exercise into an active clinical intervention.
By integrating board-certified clinical pharmacists directly into your practice’s virtual care workflow under general physician supervision, PharmD Live® resolves the root causes of non-adherence before acute complications happen.
Virtual clinical pharmacists conduct deep-dive medication reviews to eliminate financial barriers. Source: CareRX Pharmacy
During a routine monthly outreach call, Mr. S.*, a Medicare beneficiary managing hypertension and type 2 diabetes, was flagged for declining Proportion of Days Covered (PDC) scores.
A PharmD Live® Pharmacist Care Manager (PCM) conducted a comprehensive medication review and discovered that Mr. S.* had begun splitting his blood pressure tablets in half and skipping doses every other day.
High out-of-pocket co-insurance costs at his pharmacy had forced him to choose between buying groceries and filling his prescriptions.
The PCM immediately performed a therapeutic interchange review under physician collaborative protocol, identifying first-line, lower-tier generic alternatives that reduced his monthly co-pays to $0.
The PCM coordinated the prescription updates directly with his primary care provider and retail pharmacy, restoring Mr. S.* to 100% adherence and stabilizing his blood pressure readings.
*Patient details and names have been anonymized to protect privacy in compliance with HIPAA guidelines.
Proven Clinical Outcomes: Protecting Patients and Practice ROI
Deploying a pharmacist-in-the-loop adherence model delivers immediate, measurable clinical and operational returns:
- Up to 35% Increase in Adherence: Measured across high-risk chronic populations within the first 90 days of program activation.
- $1,200 Average Annual Cost Savings per Patient: Driven by fewer emergency department visits, reduced hospitalizations, and avoided adverse drug events, as corroborated by research in the New England Journal of Medicine.
- Protected CMS Star Ratings: Maintains your Part D PDC thresholds above the 80% boundary required to hit 4-Star and 5-Star quality benchmarks.
- Unburdened Practice Staff: In-house physicians and medical assistants are freed from tedious pharmacy phone calls and manual gap-closing outreach.
Action Plan for Healthcare Executives: 5 Steps to Fix Adherence
To safeguard your organization’s quality ratings and value-based revenue this year, take these five strategic actions:
- Deploy Dedicated Clinical Care Managers: Integrate virtual medication specialists into your care delivery workflow to manage high-complexity reconciliations and personalized patient education.
- Deploy Predictive Risk Analytics: Identify patients at risk of primary non-fill or declining PDC before they fall out of compliance.
- Address Financial Barriers: Establish proactive cost-transparency protocols to switch patients to lower-tier generics or manufacturer assistance programs.
- Align Care Teams Around PDC Metrics: Monitor Part D adherence metrics monthly rather than waiting for annual CMS quality reports.
- Bridge Care Across Programs: Connect adherence management seamlessly with Transitional Care Management (TCM), Chronic Care Management (CCM), and Remote Patient Monitoring (RPM) to ensure complete medication continuity.
Turn Medication Non-Adherence Into Your Strategic Advantage
Medication non-adherence is a multi-billion dollar crisis, but it is entirely solvable.
By pairing advanced virtual intelligence with clinical pharmacist oversight, your practice can protect patient lives, elevate CMS Star Ratings, and secure value-based revenue margins.
Contact PharmD Live® today to schedule your Medication Risk Management & STAR Rating Assessment.
References
- Centers for Medicare & Medicaid Services (CMS). Medicare Advantage and Part D Star Ratings Measures and Technical Notes. CMS.gov.
- World Health Organization (WHO). Adherence to Long-Term Therapies: Evidence for Action. WHO Guidelines. ISBN: 9241545992.
Google Books - Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency Hospitalizations for Adverse Drug Events in Older Americans. N Engl J Med. 2011;365(21):2002-2012. doi:10.1056/NEJMsa1103053. PMID: 22111719.
National Institutes of Health (NIH) | (.gov) - Tenpas AS, Vascimini A, et al. Improvement in Clinical Outcomes and Access to Care With Pharmacist-Led Care Management Services. J Pharm Pract. 2023;36(5):1120-1126. doi:10.1177/08971900221081333. PMID: 35938485.
- PharmD Live®. Medication Therapy Management Solutions & Pharmacist-Led Workflows. PharmD Live.
PharmD Live
